Pericardial mesothelioma is a very rare cancer that forms in the pericardium, or lining, of the heart. Tumors in the heart are very rare. Cardiac (heart) tumors are often caused by metastasis.
Written by Karen Selby, RN Edited By Walter Pacheco Medically Reviewed By Dr. Jacques Fontaine
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
- Assisting mesothelioma patients and their loved ones since 2006.
- Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
- A+ rating from the Better Business Bureau.
- 5-star reviewed mesothelioma and support organization.
"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."LashawnMesothelioma patient’s daughter
How to Cite Asbestos.com’s Article
Selby, K. (2023, February 24). Pericardial Mesothelioma. Asbestos.com. Retrieved March 23, 2023, from https://www.asbestos.com/mesothelioma/pericardial/
Selby, Karen. "Pericardial Mesothelioma." Asbestos.com, 24 Feb 2023, https://www.asbestos.com/mesothelioma/pericardial/.
Selby, Karen. "Pericardial Mesothelioma." Asbestos.com. Last modified February 24, 2023. https://www.asbestos.com/mesothelioma/pericardial/.
What Is Pericardial Mesothelioma?
Pericardial mesothelioma is a very rare type of cancer that affects the lining of the heart, called the pericardium. Less than 1% of all mesothelioma cases are pericardial.
Almost all mesotheliomas trace back to asbestos exposure. Researchers continue to study the link between asbestos and cancer of the pericardium. About 25% of people with this disease have a history of asbestos exposure. Studies are clear on how inhaled microscopic fibers reach the lungs but less clear on how the fibers may reach the heart.
This form of cancer is most often diagnosed in people between the ages of 50 and 70, with the median age being 55. According to a 2017 study published in the Journal of Clinical Oncology, approximately 60% of cases occur in men.
Like the other types of mesothelioma, the disease is typically discovered at a later stage. Symptoms include chest pain, fatigue and shortness of breath. Diagnosis is difficult because symptoms mimic those of other heart disorders.
Pericardial treatment options include surgery and chemotherapy. Palliative treatments control symptoms, and radiation therapy is rare. Surgery is the most common treatment with about 46% of patients electing surgery. About 37% receive chemotherapy and only 8% receive radiation therapy because it is risky to apply near the heart. Nearly 25% of patients elect no treatment.
A 2021 research study reported on patients with primary pericardial mesothelioma. They have a median survival of about two months. But, some people have lived for years with this cancer after undergoing surgery or chemotherapy.
To date, less than 150 cases of pericardial mesothelioma exist in the medical literature. That’s 1% of all known diagnosed mesotheliomas.
What Are the Symptoms of Pericardial Mesothelioma?
Common symptoms include difficulty breathing, chest pain and heart palpitations.
Most pericardial mesothelioma patients experience no symptoms at first. This fact contributes to a late-stage diagnosis. The symptoms also resemble those of other heart conditions. This makes it difficult to diagnose. Fluid buildup around the heart and thickening of the pericardial layers cause symptoms.
The presence of any of these symptoms warrants a visit to the doctor. Recommended tests include an X-ray, CT scan or echocardiogram (ultrasound of the heart).
The following symptoms may indicate pericardial mesothelioma:
- Difficulty breathing, even when at rest (dyspnea)
- Heart palpitations or irregular heartbeat (arrhythmia)]
- Shortness of breath when lying flat
- Chest pain
- Night sweats
If you are experiencing any of these symptoms, schedule an appointment with your doctor immediately. Screening tests reveal the underlying cause of these health problems.
What Causes Pericardial Mesothelioma?
The primary cause of pericardial mesothelioma remains a mystery. The relationship between asbestos exposure and this type of mesothelioma is not understood. Research confirms exposure to asbestos causes the pleural and peritoneal types. The causes of the pericardial type are less definitive.
A 2017 review of medical literature on pericardial mesothelioma reported asbestos exposure in 25% of cases. Another 2017 study published in the Annals of Epidemiology reported the majority of patients with pericardial mesothelioma have no history of asbestos exposure.
How Is Pericardial Mesothelioma Diagnosed?
You will receive a physical examination and imaging tests to determine the location of the tumors. A biopsy can confirm whether they are cancerous. Doctors will assess your symptoms, medical history and current medical condition.
When you see a doctor to discuss heart-related symptoms, one of the first diagnostic tests you will receive is an echocardiogram, which is essentially an ultrasound for your heart. This noninvasive test uses sound waves to help doctors see the size and shape of your heart and determine how well it is working overall.
Although an echocardiogram can reveal fluid buildup around the heart and help guide a pericardiocentesis, which is the procedure doctors perform to drain the fluid, other imaging scans are needed to determine if potential tumors are present. If doctors spot abnormal growths, they need to take a fluid or tissue sample and perform a biopsy, which can confirm a mesothelioma diagnosis.
These tumors generally are not localized, and they tend to cover most of the heart. Furthermore, this cancer type accounts for approximately half of all pericardial tumors.
Unfortunately, most cases of pericardial mesothelioma get discovered at autopsy. Nonetheless, about 10%-20% of these cases are diagnosed before a patient dies. Some of the challenges with an accurate diagnosis of the pericardial type include the small number of people with the disease and the late presentation of symptoms.
Computed tomography (CT) scans are effective for detecting pericardial tumors, making them a preferred diagnostic tool. Magnetic resonance imaging (MRI) can also yield successful results in identifying the cancer.
Radionuclide imaging is a detection method involving the injection of gallium, a radioactive material, to identify cancerous cells. It was reportedly used to detect at least one case of this type of cancer. Patterns of radioactivity show possible tumor sites in the human body.
A biopsy is a crucial diagnostic procedure. A surgeon will remove tissue or fluid from the pericardium. A microscope helps confirm if cancer is in the sample. According to a 2016 study in the Journal of Cardiac Failure, fluid biopsies often turn up cancer free even when pericardial tumors are present. A tissue sample of the tumor itself is usually required to confirm pericardial mesothelioma.
Seek a Second Opinion to Avoid Misdiagnosis
It’s important to meet with a specialist to confirm your diagnosis. To ensure an accurate diagnosis and prompt treatment, you need to speak with an expert who knows the intricacies of this rare cancer.
Pericardial mesothelioma is often mistaken for more common heart illnesses, including:
- Heart failure
- Coronary heart disease
- Tuberculosis pericarditis
- Constrictive pericarditis
- Cardiac tamponade
- Intra-atrial myxoma
If you have been diagnosed with any of these conditions, always seek a specialist to confirm the diagnosis. Working with a specialist may get you access to a wider range of treatment options, but it may also lead to improved survival.
What Treatments Are Available?
Mesothelioma treatment for pericardial mesothelioma include surgery and chemotherapy. The heart lining resting so close to the heart limits treatment options. Most therapies can easily damage this delicate organ.
Slightly more than half of patients with pericardial mesothelioma are not ideal candidates for surgery. Surgery is the most effective treatment for this cancer. But, there are rare cases where the cancer is diagnosed early and surgery can be carried out to remove small, localized tumors.
The primary treatment options for pericardial mesothelioma are pericardiectomy or tumor removal, chemotherapy and palliative treatment such as fine needle aspiration. Radiation therapy is considered minimally effective for this rare cancer and is risky to administer without harming the heart.
Pericardiectomy or Tumor Removal
Patients whose doctors decide they are good candidates for surgery are treated with a pericardiectomy or tumor removal.
A pericardiectomy is the surgical process of removing part or all of the pericardium. A pericardiectomy can relieve pressure and minimize fluid buildup, allowing the heart to continue functioning properly.
Tumor removal, also called tumor resection, can involve removal of the cancer without removing the pericardium. A 2017 review reported longer survival in patients who underwent tumor removal than patients who had a pericardiectomy.
The benefits of chemotherapy are minimal for most patients with pericardial mesothelioma. The chemotherapy drugs pemetrexed and cisplatin have shown a survival benefit. Gemcitabine has produced mixed results.
A handful of cases have responded well to chemotherapy. One woman lived longer than two years thanks to a combination of the chemotherapy drugs cisplatin, gemcitabine and vinorelbine.
Pembrolizumab, a new checkpoint inhibitor form of immunotherapy, has shown some benefit in cases of pleural mesothelioma. It may have some utility in this disease as well.
Palliative treatment options aim to minimize pain and reduce symptoms caused by the buildup of fluid in the pericardium. Essentially, palliative care can improve the quality of life and make patients more comfortable.
Palliative treatments can include therapies that relieve pain and pressure around the heart such as a pericardiocentesis or pain medication. A pericardiocentesis removes excess fluid from the pericardium to relieve pressure around the heart.
What Is the Average Prognosis?
The common prognosis for the pericardial type is poor, compared to that of peritoneal or pleural mesothelioma. Nearly 50% to 60% of pericardial patients die within six months of receiving a diagnosis. But, this is not the case for everyone.
Hope exists for some patients because researchers have cited positive results after surgery to remove local tumors. Smaller, less impactful benefits have been demonstrated from chemotherapy. Except for one case in which a 47-year-old woman was living two years after chemotherapy with cisplatin, gemcitabine and vinorelbine.
A 1995 case report of a 27-year-old woman who underwent surgery and radiation therapy for pericardial mesothelioma states that she had no evidence of recurrence during 28 years of follow-up.
A 1992 case report of a 12-year-old boy with pericardial mesothelioma who underwent surgery and chemotherapy says that he remained free of symptoms and showed no sign of disease one year later.
Surgery to remove part of the heart’s lining combined with radiation therapy improved survival in two patients in the late 1960s and early 1970s. One patient lived a year after treatment, and another was alive five years after treatment.